Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1426
Planet Labs
PL
$5.02B
| $14.4M | ﹤0.01% |
880,828
+314,338
| +55% | +$6.74M |
2022 Q2
17 quarters
|
|
1427
CALL
GameStop
GME
$13B
| $14.4M | ﹤0.01% |
585,000
-1,250,000
| -68% | -$26M |
2024 Q2
9 quarters
|
|
1428
Curbline Properties
CURB
$3.54B
| $14.4M | ﹤0.01% |
517,265
+451,145
| +682% | +$13.5M |
2024 Q4
7 quarters
|
|
1429
CALL
Ormat Technologies
ORA
$5.56B
| $14.4M | ﹤0.01% |
+157,300
| New | +$16.2M |
2026 Q3
0 quarters
|
|
1430
Brightstar Lottery PLC
BRSL
$1.77B
| $14.4M | ﹤0.01% |
1,437,998
+989,621
| +221% | +$10.8M |
2013 Q2
53 quarters
|
|
1431
CNO Financial Group
CNO
$5.25B
| $14.4M | ﹤0.01% |
271,309
+138,598
| +104% | +$7.5M |
2015 Q4
43 quarters
|
|
1432
Allegion
ALLE
$16.3B
| $14.4M | ﹤0.01% |
93,347
-36,712
| -28% | -$5.64M |
2013 Q4
51 quarters
|
|
1433
Materion
MTRN
$4.25B
| $14.3M | ﹤0.01% |
52,948
+37,969
| +253% | +$9.5M |
2013 Q2
53 quarters
|
|
1434
argenx
ARGX
$60.4B
| $14.3M | ﹤0.01% |
14,881
-119,546
| -89% | -$112M |
2024 Q3
8 quarters
|
|
1435
New York Times
NYT
$11.6B
| $14.2M | ﹤0.01% |
223,551
+172,853
| +341% | +$12M |
2013 Q2
53 quarters
|
|
1436
PUT
On Holding
ONON
$11.3B
| $14.2M | ﹤0.01% |
480,000
-100,000
| -17% | -$3.26M |
2024 Q3
8 quarters
|
|
1437
Oruka Therapeutics
ORKA
$7.15B
| $14.2M | ﹤0.01% |
170,500
+95,738
| +128% | +$9.02M |
2024 Q4
7 quarters
|
|
1438
BioNTech
BNTX
$21.2B
| $14.2M | ﹤0.01% |
144,449
-40,214
| -22% | -$3.9M |
2022 Q1
18 quarters
|
|
1439
Cytokinetics
CYTK
$7.82B
| $14.2M | ﹤0.01% |
215,430
+144,788
| +205% | +$11M |
2013 Q3
52 quarters
|
|
1440
Flutter Entertainment
FLUT
$14.1B
| $14.2M | ﹤0.01% |
190,460
-81,588
| -30% | -$8.1M |
2024 Q1
10 quarters
|
|
1441
Chewy
CHWY
$9.05B
| $14.2M | ﹤0.01% |
779,339
-148,134
| -16% | -$3.23M |
2019 Q3
28 quarters
|
|
1442
PBF Energy
PBF
$8.45B
| $14.2M | ﹤0.01% |
184,179
-11,555
| -6% | -$782K |
2013 Q2
53 quarters
|
|
1443
Archrock
AROC
$4.8B
| $14.1M | ﹤0.01% |
466,873
+427,860
| +1,097% | +$14.5M |
2013 Q2
53 quarters
|
|
1444
Elanco Animal Health
ELAN
$13.4B
| $14.1M | ﹤0.01% |
631,449
+454,197
| +256% | +$11M |
2018 Q3
32 quarters
|
|
1445
IMAX
IMAX
$2.67B
| $14.1M | ﹤0.01% |
257,793
+6,122
| +2% | +$297K |
2015 Q1
46 quarters
|
|
1446
CALL
MiniMed Group Inc
MMED
$5.06B
| $14.1M | ﹤0.01% |
+725,000
| New | +$13.9M |
2026 Q3
0 quarters
|
|
1447
DELISTED
CBIZ
CBZ
| $14.1M | ﹤0.01% |
257,880
+143,723
| +126% | +$7.23M |
2013 Q2
53 quarters
|
|
1448
Encore Capital Group
ECPG
$2.28B
| $14M | ﹤0.01% |
148,646
-75,902
| -34% | -$7.28M |
2013 Q2
53 quarters
|
|
1449
Krystal Biotech
KRYS
$9.05B
| $14M | ﹤0.01% |
42,199
+34,763
| +467% | +$12M |
2018 Q4
31 quarters
|
|
1450
Portland General Electric
POR
$5.47B
| $14M | ﹤0.01% |
314,152
-300,834
| -49% | -$15M |
2013 Q2
53 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.